Zosano Pharma Corp Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum

Zosano Pharma Corp Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum

Zosano Pharma Corp reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum of 122.86% for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-17.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum · last filed 2022-03-17

• Zosano Pharma Corp share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2021 was 122.86%, a 2.03% increase from fiscal 2020.
• Zosano Pharma Corp share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2020 was 120.42%, a 11.75% increase from fiscal 2019.
• Zosano Pharma Corp share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2019 was 107.76%.